Stockreport

Kronos Bio Announces Participation in Medical and Investor Conferences in September [Yahoo! Finance]

Kronos Bio, Inc.  (KRON) 
PDF molecule therapeutics that address cancers and other diseases driven by deregulated transcription, today announced the following upcoming conferences: H.C. Wainwright [Read more]